Vonoprazan-Based Triple Therapy in Comparison With Extended Sequential Therapy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study aims to compare the efficacy of the current standard first-line anti-helicobacter pylori regimen, extended proton pump inhibitor-based sequential therapy, with that of vonoprazan-based triple therapy, through a randomized controlled trial.
Epistemonikos ID: 26309018639618399c687cd28b5105d74fd393f2
First added on: May 13, 2024